Number of participating innovations and countries per year 2007-2023

Country

Prize

Organization

Innovation

Description

Country

Estonia

Prize

Honorable mention

Organization

Competence Centre for Cancer Research Ltd

Innovation

Complex service of oncogenetic consultations and testing

Description

Establish a decision system through big data analysis to enable the visual display of real time quality data of all production processes, intelligent detection and prediction of any quality abnormity, and automatically manage quality activities in digital way.

Country

Estonia

Prize

Microenterprises

Organization

Feanor OU

Innovation

Pinetree solid carbide cutters

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Estonia

Prize

Small and medium sized enterprises

Organization

Bio-Competence Centre of Healthy Dairy Products LLC

Innovation

Lactobacillus planatrum TENSIA

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Large companies

Organization

Kemppi Oy

Innovation

Kemppi Datastore

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Large companies

Organization

Tallink Silja Oy

Innovation

Silja Line 1000 product developers

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Microenterprises

Organization

CWP Coloured Wood Products Oy

Innovation

Through colour water-soluble wood dyes

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Potential innovations

Organization

The Finnish Meteorological Institute

Innovation

Electric solar wind sail

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Public sector and nonprofit organizations

Organization

National land Survey of Finland

Innovation

Paikkatietoikkuna - Finnish Geoportal

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Small and medium sized enterprises

Organization

Vahanen Oy

Innovation

PutkiremonttiPlus Service Model

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.